US Patent Issued to Mapi Pharma on Feb. 18 for "Depot systems comprising glatiramer or pharmacologically acceptable salt thereof" (Israeli Inventors)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. RE50,301, issued on Feb. 18, was assigned to Mapi Pharma Ltd. (Ness Ziona, Israel).

"Depot systems comprising glatiramer or pharmacologically acceptable salt thereof" was invented by Ehud Marom (Tel Aviv, Israel) and Shai Rubnov (Tel Aviv, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "Long acting parenteral pharmaceutical compositions comprising a therapeutically effective amount of glatiramer are provided. In particular, the present invention provides a long acting pharmaceutical composition comprising a therapeutically effective amount of glatiramer acetate in depot form suitable for administering at a medically acceptable location in a subject i...